Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii
About Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Clinical Trials at Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii
During the past decade, Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
2018-06-11
2020-10-07
Completed
1,235
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2020-06-11
2021-07-13
Completed
727
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii
According to Clinical.Site data, the most researched conditions in "Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii" are
"Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials), "Dermatitis" (1 trials), "Eczema" (1 trials) and "Genetic Diseases, Inborn" (1 trials). Many other conditions were trialed in "Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii" in a lesser frequency.
Clinical Trials Intervention Types at Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii
Most popular intervention types in "Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii" are "Drug" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abrocitinib 200 mg" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Dupilumab 300 mg" (1 trials) and "PF-04965842 100 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii
The vast majority of trials in "Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii" are
3 trials for "All" genders.
Clinical Trials Status at Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii
Currently, there are NaN active trials in "Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".